NICE Delivers More Good News for Cervical Cancer Patients

NICE delivers more good news for cervical cancer patients

Hundreds of women with locally advanced cervical cancer are to be offered MSD's Keytruda on the NHS in England, thanks to new NICE guidance.

New cervical cancer treatment to be made available

New cervical cancer treatment to be made available dannyadmin 25 June, 2026 New cervical cancer treatment to be made available 25 June, 2026 A new immunotherapy treatment is to be offered to women with aggressive cervical cancer which could help more women survive and stay cancer-free in the long-term.Pembrolizumab – which experts describe as being able to ‘take the handbrake off the body’s immune system’ to target cancer – will now offer a n…

NICE recommends MSD’s pembrolizumab for locally advanced cervical cancer

First immunotherapy approved for LACC in England offers new treatment option for women

NHS rolls out new immunotherapy for women with advanced cervical cancer – NATIONAL NEWS

Hundreds of women with advanced cervical cancer in England are set to benefit from a new NHS treatment that could significantly improve survival rates and help keep the disease from returning. The immunotherapy drug pembrolizumab has been approved for NHS use in combination with standard chemoradiotherapy for patients with stages three and four locally advanced cervical cancer. The treatment is aimed at women whose cancer has spread beyond the c…

NHS England » NHS to offer new immunotherapy for hundreds of women with aggressive cervical cancer

Hundreds of women with aggressive cervical cancer are to be offered a new immunotherapy on the NHS, which could help more women survive and stay cancer-free in the long-term. Pembrolizumab – which experts describe as being able to ‘take the handbrake off the body’s immune system’ to target cancer – will now offer a new […]